AVITA Medical to Host Investor Webinar Briefing

Rhea-AI Summary

AVITA Medical (NASDAQ: RCEL, ASX: AVH) will host an investor webinar briefing on August 12, 2026, at 4:00 p.m. Pacific Time (August 13, 2026, 9:00 a.m. AEST). President and CEO Cary Vance and CFO David O’Toole will present financial and business highlights from the recent Q2 2026 earnings webcast, followed by a Q&A session. Investors can register via Zoom, and a replay will be available on the AVITA Medical investor relations website.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

VALENCIA, Calif., Aug. 09, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, invites shareholders and prospective investors to attend its investor webinar briefing and presentation by Cary Vance, President and Chief Executive Officer, and David O’Toole, Chief Financial Officer, on August 12, 2026, at 4:00 p.m. Pacific Time (August 13, 2026, at 9:00 a.m. Australian Eastern Standard Time).

The webinar presentation will cover financial and business results from AVITA Medical’s recent second-quarter 2026 earnings webcast and will conclude with a Q&A session. Participants are invited to submit their questions via the registration page.

To register for the presentation, please follow this Zoom link: https://us06web.zoom.us/webinar/register/WN_xMCmMLjTQeiyNQm6YzJrZQ

A replay will be available on the AVITA Medical website at: https://ir.avitamedical.com/events-and-presentations

About AVITA Medical, Inc.

AVITA Medical® is a leading therapeutic acute wound care company delivering transformative solutions. Our technologies are designed to optimize wound healing, effectively accelerating the time to patient recovery. At the forefront of our platform is RECELL®, approved by the FDA for the treatment of thermal burn and trauma wounds. RECELL harnesses the healing properties of a patient’s own skin to create Spray-On Skin™, offering an innovative solution for improved clinical outcomes at the point-of-care. In the U.S., AVITA Medical also holds the exclusive rights to market, sell, and distribute Cohealyx®, an AVITA Medical-branded collagen-based dermal matrix, and the exclusive rights to manufacture, market, sell, and distribute PermeaDerm®, a biosynthetic wound matrix.

In international markets, RECELL is approved to promote skin healing in a wide range of applications, including thermal burn and trauma wounds. RECELL and RECELL GO® are CE-marked in Europe, have TGA certification in Australia, and are listed with Medsafe in New Zealand; RECELL is PMDA-approved in Japan.

To learn more, visit www.avitamedical.com.

Investor & Media Contact:
Ben Atkins
Phone +1-805 341 1571
investor@avitamedical.com | media@avitamedical.com

Authorized for release by the Chief Financial Officer of AVITA Medical, Inc.

©2026 AVITA Medical. AVITA Medical®, the AVITA Medical logo, Cohealyx®, RECELL®, RECELL GO®, and Spray-On Skin^TM Cells are trademarks of AVITA Medical. PermeaDerm® is a registered trademark owned by Stedical Scientific, Inc. All other trademarks are the properties of their respective owners.

FAQ

When is the AVITA Medical (NASDAQ: RCEL) investor webinar briefing scheduled?

The AVITA Medical investor webinar is scheduled for August 12, 2026, at 4:00 p.m. Pacific Time. According to AVITA Medical, this corresponds to August 13, 2026, at 9:00 a.m. Australian Eastern Standard Time, enabling participation from both U.S. and Australian investors.

How can investors register for the AVITA Medical (RCEL) investor webinar on August 12, 2026?

Investors can register for the AVITA Medical webinar via a dedicated Zoom registration link. According to AVITA Medical, participants should follow the provided Zoom URL to complete registration and will then receive access details for joining the online investor briefing and presentation.

What topics will be covered during the AVITA Medical (RCEL) August 2026 investor webinar?

The webinar will cover financial and business results discussed in AVITA Medical’s recent Q2 2026 earnings webcast. According to AVITA Medical, the session will include management’s presentation and will conclude with a Q&A segment where investors can have submitted questions addressed.

Who will present at the AVITA Medical (NASDAQ: RCEL) investor webinar briefing?

The investor webinar will be presented by Cary Vance, President and Chief Executive Officer, and David O’Toole, Chief Financial Officer. According to AVITA Medical, these executives will review second-quarter 2026 financial and business results and participate in a concluding Q&A session.

Will a replay of the AVITA Medical (RCEL) August 2026 investor webinar be available?

Yes, a replay of the investor webinar will be available after the event. According to AVITA Medical, investors can access the replay on the company’s investor relations website under the events and presentations section for on-demand viewing.

How can investors submit questions for the AVITA Medical investor webinar Q&A session?

Investors can submit questions through the webinar registration page before or during sign-up. According to AVITA Medical, these submitted questions may be addressed during the Q&A portion that concludes the investor webinar briefing.